ClinicalTrials.Veeva

Menu

EFFECTS OF RejuvaMatrix ™ ON TELOMERES

H

Holos Institutes of Health, Inc

Status and phase

Completed
Phase 1

Conditions

Telomeres

Treatments

Device: Exposure to GHz electromagnetic energy (RejuvaMatrix)

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Lying for 30 to 60 minutes daily in a field of 75 decibels of electromagnetic energy at 54 to 78 GHz will allow telomeres of white blood cells to regenerate

Full description

Individuals who are post menopausal and who do not have an implanted electronic device, such as a pacemaker will have base line white blood cell telomeeres measured at Repeat Diagnostics in Vancouver. They will be supplied with a two inch foam mat in the center of which is copper screen with one pound of crushed sapphire. The mat looks like a mattreess and is placed on top of the regular mattress. Participants are provided with a Tesla coil to be attached to a copper wire coming from the copper screen. They will also be provided with a timer so that they can set the Tesla coil to be activated for a maximum of 60 minutes while they sleep.

Telomeres will be measured at the end of each year for 5 years.

Enrollment

50 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Exclusion criteria

  • Implanted electronic device
  • Major, debilitating disease
  • Person living with an individual who has an implanted device
  • Person who is or could become pregnant

Trial design

Primary purpose

Supportive Care

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

Telomere length, GigaHz exposure
Active Comparator group
Description:
Measurement of white blood cell telomeres before and yearly for 5 years
Treatment:
Device: Exposure to GHz electromagnetic energy (RejuvaMatrix)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems